DALIVIT- ascorbic acid, folic acid, thiamine hydrochloride, riboflavin, niacinamide, pyridoxine hydrochloride, cyanocobalamin and calcium pantothenate capsule, coated
DAIVIT is a prescription multi-vitamin in the form of a red, oval, softgel.
DALIVIT is a prescription multi-vitamin supplement that can be taken to improve nutritional status in conditions requiring dietary supplementation. DALIVIT can also be used for the dietary management of individuals with distinct nutritional needs under a physician or healthcare provider’s supervision for end stage failure, dialysis, hyperhomocysteinemia or inadequate dietary vitamin intake.
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Folic Acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematological remission can occur while neurological manifestations remain progressive. Folic Acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.
DO NOT EXCEED RECOMMENDED DOSAGE.
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
Folic Acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematological remission can occur while neurological manifestations remain progressive. The 1 mg of cyanocobalamin contained in DALIVIT Softgels has been shown to provide an adequate amount of cyanocobalamin to address this precaution. A safer upper limit of 100 mg per day has been established for the unsupervised medical use of pyridoxine. Consider all sources of pyridoxine supplementation when prescribing DALIVIT Softgels.
If pregnant, or planning to become pregnant or are currently breast-feeding please contact your physician, or healthcare provider before using or continuing use of this medication.
Allergic sensitization has been reported following both oral and parenteral administration of folic acid. Paresthesia and somnolence have been reported with the use of pyridoxine hydrochloride. Mild transient diarrhea, polycynthemia vera, peripheral vascular thrombosis, itching transitory exanthema and feeling of swelling of the entire body has been associated with the use of cyanocobalamin.
Pyridoxine supplements should not be given to patients receiving the drug levodopa, because the action of levodopa is antagonized by pyridoxine. However, pyridoxine may be used concurrently in patients receiving a preparation containing both carbidopa and levodopa. Concurrent use of phenytoin and folacin (folic acid) may result in decreased phenytoin effectiveness.
DOSAGE AND ADMINISTRATION
Adults: One Softgel taken orally daily or as directed by a physician.
DO NOT EXCEED RECOMMENDED DOSAGE.
|Serving Size: 1 Softgel||Servings per Container: 30|
|Amount Per Serving||% Daily Value|
|Vitamin C (as Ascorbic Acid)||100mg||167%|
|Vitamin B1 (as Thiamine HCl)||2mg||133%|
|Vitamin B2 (as Riboflavin)||2mg||117%|
|Vitamin B3 (as Niacinamide)||20mg||100%|
|Vitamin B6 (as Pyridoxine HCl)||10mg||400%|
|Vitamin B12 (as Cyanocobalamin)||1mg||16,667%|
|Pantothenic Acid (as Calcium Pantothenate)||10mg||100%|
Store at 20° — 25°C (68° — 77°F); excursions permitted to 15° — 30°C (59° — 86°F) [See USP Controlled Room Temperature.]
Protect from light and moisture.
Dispense in a well-closed, tight, light-resistant container as defined by the USP using a child resistant closure.
DALIVIT softgels are supplied as red softgel. DALIVIT softgels are available in bottles of 30 (70877-8243-3). Each softgel of Dalivit contains 100 mg ascorbic acid, 1 mg of Folic Acid, 2 mg of thiamine hydrochloride, 2 mg of riboflavin, 20 mg of niacinamide, 10 mg of pyridoxine hydrochloride, 1 mg of cyanocobalamin, and 10 mg of calcium pantothenate.
Taleos Pharma Corp.
Eatontown, NJ 07724
Rx Only 30 SOFTGELS
| DALIVIT |
ascorbic acid, folic acid, niacinamide, thiamine hydrochloride, riboflavin, pyridoxine hydrochloride, cyanocobalamin and calcium pantothenate capsule, coated
|Labeler — Taleos Pharma (080318529)|
Revised: 04/2018 Taleos Pharma
DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.